Lipid nanoparticle encapsulated TLR3 agonist adjuvant elicits potent T cell immunity against cancer and viruses.
Saved in:
| Title: | Lipid nanoparticle encapsulated TLR3 agonist adjuvant elicits potent T cell immunity against cancer and viruses. |
|---|---|
| Authors: | Ko KH; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Lee SH; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Choi YH; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Kang SM; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Yang HS; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Lee SM; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Jo EB; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Bae HS; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Hong SB; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea., Kim DH; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea. dhk@navaccine.org., Cha SB; R&D Center, NA Vaccine Institute, Seoul, Republic of Korea. sbcha@navaccine.org. |
| Source: | NPJ vaccines [NPJ Vaccines] 2025 Dec 23; Vol. 11 (1), pp. 26. Date of Electronic Publication: 2025 Dec 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2059-0105 |
|---|---|
| DOI: | 10.1038/s41541-025-01349-w |
